Clinical Trials

Patient participation in cancer clinical trials (CCTs), is critical to the discovery of new treatments and medications.  CCTs are becoming a measure for quality cancer care, and therapies offered through clinical trials are being considered the preferred treatment choice for physicians and patients. But patient participation in CCTs remains low.…

In the ever-advancing world of medicine, access to a cutting-edge clinical trial treatment can help determine a cancer patient’s future. Although 20 percent of cancer patients are eligible for treatment clinical trials, participation hovers around three to five percent. Moreover, patients from racial and ethnic minority groups and underserved populations…